FLUORECENT EBV-EARLY ANTIGEN IGG ANTIBODY TEST SYS— 510(k) K912488
Substantially EquivalentImmuno Concepts, Inc.
FDA 510(k) clearance K912488 for FLUORECENT EBV-EARLY ANTIGEN IGG ANTIBODY TEST SYS, Substantially Equivalent on 1991-07-24. Applicant: Immuno Concepts, Inc.. Device class: 1.
Clearance details
- Applicant
- Immuno Concepts, Inc.
- Product code
- Code LSE
- Device class
- Class 1
- Regulation
- 21 CFR 866.3235
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Sacramento, CA, US
Recent devices under product code LSE
view all- K233606 — ADVIA Centaur EBV-VCA IgM
- K162961 — LIAISON® VCA IgG and LIAISON® VCA IgG Serum Control Set; LIAISON® EBNA IgG and LIAISON® EBNA IgG Serum Control Set
- K162959 — LIAISON® EA IgG and LIAISON® EA IgG Serum Control Set
- K091260 — SERAQUEST EBV EA-D IGG TEST
- K073382 — PLEXUS EBV IGG MULTI-ANALYTE DIAGNOSTICS, MODEL: MP0500G
More clearances from Immuno Concepts, Inc.
view all- K013432 — IGG ANTI-NDNA FLUORESCENT TEST SYSTEM; MODEL # 3040G
- K013283 — RELISA PR3-ANCA TEST SYSTEM FOR ANTIBODIES TO PROTEINASE 3, MODEL # 7096-16
- K013285 — RELISA MPO-ANCA TEST SYSTEM FOR ANTIBODIES TO MYELOPEROXIDASE, MODEL # 7096-15
- K992041 — RELISA ANA SCREENING TEST SYSTEM, MODEL 7096-11
- K983924 — HEP-2000 COLORZYME ANA-RO TEST SYSTEM, MODEL 4200-RO
Data sourced from openFDA. This site is unofficial and independent of the FDA.